Two frequent polymorphisms of angiotensinogen and their association with multiple sclerosis progression rate

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.
Authors

HLADÍKOVÁ Magdaléna VAŠKŮ Anna ŠTOURAČ Pavel BENEŠOVÁ Yvonne BEDNAŘÍK Josef

Year of publication 2011
Type Article in Periodical
Magazine / Source Journal of the Neurological Sciences
MU Faculty or unit

Central European Institute of Technology

Citation
Doi http://dx.doi.org/10.1016/j.jns.2011.01.020
Field Traumatology and orthopaedic surgery
Keywords Multiple sclerosis; Angiotensin converting enzyme; Angiotensinogen; Polymorphism; Neuroinflammation
Description A total of 195 patients with multiple sclerosis (MS) and 126 controls were investigated for angiotensinogen/(-6)A/G, M235T/and angiotensin converting enzyme I/D gene polymorphisms to test their association with MS susceptibility and/or disease progression using Global Multiple Sclerosis Severity Score (MSSS). We demonstrated a significant association of M235T polymorphism with MSSS. The MM homozygotes had the lowest (3.8), heterozygotes MT higher (5.2) and homozygotes TT the highest (5.4) mean MSSS values (P = 0.02). For polymorphisms (-6)A/G of ATG, only a trend was observed (P = 0.06), where the homozygotes GG carried lower MSSS values than heterozygotes and homozygotes AA. No significant association with susceptibility was observed. For ACE I/D polymorphism, neither significant differences in the genotype-phenotype study nor in the case-control study were observed.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.